Term
|
Definition
Protein therapeutics with enzymatic or regulatory activity |
|
|
Term
|
Definition
Replace a protein which is deficient or abnormal
• Factor VIII • Insulin and its analogues • Growth Hormone |
|
|
Term
|
Definition
Augment an existing pathway
• Erythropoietin • Pegylated interferon • Tenecteplase |
|
|
Term
|
Definition
Provide a novel function or activity
• Collagenase • L-asparaginase • Etanercept |
|
|
Term
|
Definition
Protein therapeutics with special targeting activity |
|
|
Term
|
Definition
Interfering with a molecule or organism by binding to it and blocking its function or targeting it for degradation
• Abciximab
• Enfuviritide • Infliximab |
|
|
Term
|
Definition
Stimulating a signalling pathway
• Trastuzumab |
|
|
Term
|
Definition
Delivering other compounds or proteins
• Gemtuzumab ozagamicin |
|
|
Term
|
Definition
|
|
Term
|
Definition
Protecting against a deleterious foreign agent
• HBsAg • Lyme disease (Borrelia burgdorfei) |
|
|
Term
|
Definition
Treating an autoimmune disease
• Anti-Rh IgG |
|
|
Term
|
Definition
Treating cancer
• Currently in clinical trials |
|
|
Term
|
Definition
Protein diagnostic
HIV antigens Hepatitis C antigens Thyroid stimulating hormone (TSH) Glucagon |
|
|
Term
Sympathetic preganglionic neurons |
|
Definition
arise in the ventral horn of the thoracic and lumbar segments of the spinal cord and project onto postganglionic neurons in the paravertebral and prevertebral ganglia. Sympathetic postganglionic neurons innervate many organs, including smooth muscle. • The adrenal medulla is innervated by preganglionic neurons of the sympathetic nervous system |
|
|
Term
Parasympathetic preganglionic neurons |
|
Definition
arise in nuclei in the brainstem/sacral segments of the spinal cord and project onto postganglionic neurons in ganglia located near the innervated organs. |
|
|
Term
|
Definition
Pharmacological M-agonist bethanecol (GI and urinary tract motility) M-antagonist atropine (dilate pupils/ increase heart rate) action |
|
|
Term
|
Definition
Albuterol (B2 agonist) dilate bronchioles selectively vs. Metroprolol (B2 antagonist) selectively decrease heart rate |
|
|
Term
|
Definition
(agonist of NMJ) increase skeletal muscle stimulation (Myasthenia gravis treatment) |
|
|
Term
|
Definition
(antagonist of NMJ) induces paralysis |
|
|
Term
|
Definition
parasympathetic and somatic neuromuscular junctions. Few sympathetic neuroeffector junctions; sweat glands and vasodilator fibers in skeletal muscle. lack of specificity of drugs acting on acetylcholine neurotransmission |
|
|
Term
o Norepinephrine/ Ephinephrine |
|
Definition
Norepinephrine (noradrenaline) - Primary neurotransmitter at most sympathetic postganglionic neuroeffector junctions, Epinephrine (adrenaline) is the principal catecholamine released from the adrenal medulla |
|
|
Term
o Other neurotransmitters |
|
Definition
autonomic nerves of the GI tract, genitourinary tract and certain blood vessels. neuropeptide Y, vasoactive intestinal polypeptide, enkephalin, substance P, serotonin, adenosine triphosphate, and nitric oxide. |
|
|
Term
|
Definition
o Parasympathetic neuroeffector junctions o M1-M5 human GPCR – G-Protein Coupled Receptor M3 receptor- smooth muscle contraction and gland secretion. M2 receptor- mediates cardiac slowing M1 receptor -modulation of neurotransmission at central and peripheral sites. o Activation in skeletal muscle causes muscle contraction. o M1, M3 and M5 stimulation of PLC, IP3 and DAG o M2 and M4 inhibition AC and K+ channel activation o Hyperpolarization of the cell o Latency 100-250 ms |
|
|
Term
Nicotinic receptor action |
|
Definition
o Found in all autonomic ganglia (Nn neuron Nm muscle) o NN –Neuronal- excites neurotransmission o NM –somatic neuromuscular – excites muscle contraction o NM:5 subunits; 30-50% homology o NN: and subunits |
|
|
Term
Nicotinic receptor structure biology |
|
Definition
o 2 subunit - hydrophobic pocket serves as binding site for Ach agonist o Predominant ion in nAChR is Na+, o Net inward Na+ current depolarize the cell o Brief latency <10ms |
|
|
Term
Synthesis of Achetylcholine |
|
Definition
o Choline sources: Synaptic Cleft Plasma based (lipid phosphatidylcholine)1 Phospholipids (phosphorylcholine) o Acetyl-CoA: Glycolysis (mitochondria)2 o Rate limiting steps of ACh: Choline uptake Low affinity facilitated diffusion (Km=10-100M) High affinity transport (Km=1-5M) 3 |
|
|
Term
Cholinergic Neurotransmission |
|
Definition
o direct-acting acetylcholine receptor agonists : bethanechol and pilocarpine, o indirect-acting acetylcholine receptor agonists: cholinesterase inhibitors (physostigmine), increase the synaptic concentration of Ach. o acetylcholine receptor antagonists: o muscarinic receptor antagonists (atropine) o nicotinic receptor antagonists /ganglionic blocking agents (e.g., trimethaphan) and neuromuscular blocking drugs (e.g., tubocurarine). |
|
|
Term
Effects of Acetylcholine on M receptors |
|
Definition
o Eye iris contraction and miosis o Salivary and lacrimal glad thin and watery secretions o Heart Bradycardia Lower conduction velocity AV block in high doses Slight lower in contractility |
|
|
Term
How does botulinum toxine cause muscle weakness and prolonged paralysis? |
|
Definition
o Degrades synaptobrevin and prevents the fusion of presynaptic storage vesicles with the cell membrane |
|
|
Term
• A woman with facial muscle spasms is treated with an agent that inhibits the release of acetylcholine. Which side effect is most likely to occur in this patient? |
|
Definition
|
|
Term
|
Definition
Norepinephrine (NE), the principal transmitter of most sympathetic postganglionic fibers dopamine (DA), the predominant transmitter of the extrapyramidal system, mesocortical and mesolimbic neuronal pathways epinephrine, the major hormone of the adrenal medulla |
|
|
Term
|
Definition
• mediate smooth muscle and glands contraction |
|
|
Term
|
Definition
• cause transmitter release, contraction |
|
|
Term
Activation of β1-adrenoceptors |
|
Definition
• produces cardiac stimulation |
|
|
Term
|
Definition
• mediate smooth muscle relaxation |
|
|
Term
Adrenergic Neurotransmition |
|
Definition
Direct- acting adrenoceptor agonists - albuterol, epinephrine Indirect- acting adrenoceptor agonists • Amphetamine(+), cocaine(-) o Acts on reuptake of NE • COMT or MAO inhibitors (primarily effects on CNS ) |
|
|
Term
|
Definition
selectively blocks α-adrenoceptors |
|
|
Term
|
Definition
selective β-adrenoceptors blocker |
|
|
Term
Inhibit synthesis of neurotransmitter |
|
Definition
• Hemicholinium • Metyrosine (alpha-methyl-para-tyrosine) |
|
|
Term
Prevent vesicular storage of neurotransmitter |
|
Definition
|
|
Term
Inhibit release of neurotransmitter |
|
Definition
• Botulinum toxin • Bretylium |
|
|
Term
Increase release of neurotransmitter |
|
Definition
• Black widow spider venom (α-latrotoxin)* • Amphetamine |
|
|
Term
Inhibit reuptake of neurotransmitter |
|
Definition
|
|
Term
Inhibit metabolism of neurotransmitter |
|
Definition
• Cholinesterase inhibitors (physostigmine) • Monoamine oxidase inhibitors (phenelzine) |
|
|
Term
Activate postsynaptic receptors |
|
Definition
• Acetylcholine, bethanechol, and pilocarpine • Albuterol, dobutamine, and epinephrine |
|
|
Term
Block postsynaptic receptors |
|
Definition
• Atropine and tubocurarine (block muscarinic and nicotinic receptors, respectively) • Phentolamine and propranolol (block α- and β-adrenoceptors, respectively) |
|
|
Term
o Epinephrine/Norepinephrine …? |
|
Definition
Are released by adrenal medulla pon binding to 2 adrenoceptors Ep cause smooth muscle relaxation |
|
|
Term
o In a sympathetic postganglionic nerve ending which of the following blocks the conversion of an intermediate amino acid? |
|
Definition
|
|
Term
|
Definition
Cortex- site of action of many drugs Basal ganglia - intended actions , movement (PD) Limbic system: cingulate gyrus, Hippocampus, amygdala- emotions, social behaviour (AD) |
|
|
Term
o Pharmcological modification of Brain regions |
|
Definition
Barbiturates and Benzodiazepines hypnotic/sedetative agents potentiate the action of inhibitory neurotransmitters in cortex. Levodopa acts on the dopaminergic neurotransmission and ameliorates symptoms of Parkinson disease in striatum Drugs that affect limbic system (hippocampus) and cholinergic neurotransmittion are used in Alzheimers Disease |
|
|
Term
o Neurotrasmitters in CNS |
|
Definition
Exitatory (E, D) Inhibitary (G, GABA) Glutamate act on both ionotropic and metabotropic receptors • Overactivation of glutamate receptors lead to ischemic brain injury (neuronal death) • Felbamate o used in treatment of refractory epilepsy o inhibits NMDA receptors -> reduce excessive neuronal activity GABA acts on GABA receptors • Barbiturates and benzodiazepines and potentiate the effect of endogenous GABA |
|
|
Term
|
Definition
• Subtantia niagra-control intended actions/ movements (PD –SN degeneration) |
|
|
Term
|
Definition
• Locus ceruleus- maintain vigilance, responsiveness to unexpected stimulus • COCAIN- activate this system by inhibiting reuptake of norepinephrine – Hypervigilance • TCA (antidepressant) blocks reuptake of NE |
|
|
Term
|
Definition
• Brain stem (raphe nuclei) – modulating pain, regulate wakeness/ sleep • Depression- dysfunction of seretonin system • (SSRIs- used for treatment of depression) |
|
|
Term
|
Definition
• Nucleus : Alertness/ sleep-awake cykle, AD |
|
|
Term
|
Definition
• Hypothalamus: forbrain arousal. Antihistamines • (H1 receptor antagonist) used to treat allergies. |
|
|
Term
|
Definition
Peripheral mechanism of action: Its released from nerves (nitrergic) innervating blood vessels and smooth muscles of the GI Endothelial cell–dependent mechanisms of relaxation including the coronary circulation. Activates specific GPCRs ->promotes NO production. activating GC-> cyclic GMP Nitrovasodilating act through conversion to or release of NO CNS mechanism of action:. NO is a small protein neurotransmitter • Binds to receptors residing in the presynaptic neuron. |
|
|
Term
|
Definition
Endocrine, aoutocrine and paracrine effects Opioids, Tachykinins, Secretins, Insulines Piturary hormone release : CRH, GnRH, TRH, GRH Opioid receptors in the spinal cord and brain mostly involved in pain sensation: Pharmacological targets of analgesics (morphine) and drug abuse (heroin) |
|
|
Term
o Blood Brain Barrier (BBB) permeability |
|
Definition
Lipophilic substances, incl lipid soluble gases • high w/o coefficient pass BBB Hydrophilic substances (glucose) pass BBB only with help of specific transporters Hexose transportes glucose 3 transporters involved in the transport of amino acids (L-DOPA but not dopamine) Protection against toxic substances • Multiple drug resistance transporters • Metabolic BBB |
|
|